The point is, they haven't finished trialling it yet and still gave it to patients even given its history. If a relative of mine were going to be given a cancer drug I would want to know that it had been fully trialled first, especially if they were dying (and my father did die of cancer, in fact).
They aren't going to know the true effects or incidence of secondary cancers until they finish investigating so the public aren't aware yet of the true benefit (or not) of this drug.
Comment Reply
The point is, they haven't finished trialling it yet and still gave it to patients even given its history. If a relative of mine were going to be given a cancer drug I would want to know that it had been fully trialled first, especially if they were dying (and my father did die of cancer, in fact).
April 17, 2011 - 4:26amThey aren't going to know the true effects or incidence of secondary cancers until they finish investigating so the public aren't aware yet of the true benefit (or not) of this drug.
This Comment
Reply